Acquired long QT interval: A case series of multifactorial QT prolongation

Clinical Cardiology

Volumn 34, Issue 9, 2011, Pages 577-582

  Digby, Geneviãve C ^a   Pérez Riera, Andrés Ricardo ^b   Barbosa Barros, Raimundo ^c   Simpson, Christopher S ^a   Redfearn, Damian P ^a   Methot, Michelle ^a   Femenía, Francisco ^d   Baranchuk, Adrian ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b FACULDADE DE MEDICINA DO ABC   (Brazil)

^c Hospital de Messejana Dr Carlos Alberto Studart Gomes   (Brazil)

^d HOSPITAL ESPAÑOL DE MENDOZA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; DIURETIC AGENT;

ADULT; ALCOHOL ABUSE; BRADYCARDIA; CASE STUDY; CLINICAL ARTICLE; CLINICAL FEATURE; COMPLETE HEART BLOCK; CONGESTIVE CARDIOMYOPATHY; DISEASE COURSE; ELECTROCARDIOGRAM; FEMALE; HUMAN; HYPERTENSION; HYPOCALCEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; MAGNESIUM BLOOD LEVEL; MALE; PACEMAKER; POLYPHARMACY; POTASSIUM BLOOD LEVEL; QT INTERVAL; QT PROLONGATION; REVIEW; RISK FACTOR; SLEEP APNEA SYNDROME; TORSADE DES POINTES;

ADULT; AGED; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; FEMALE; HUMANS; LONG QT SYNDROME; MALE; MIDDLE AGED; POLYPHARMACY; POTASSIUM CHANNELS; RETROSPECTIVE STUDIES; RISK FACTORS; TORSADES DE POINTES; YOUNG ADULT;

EID: 80052773761     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20945     Document Type: Review

References (26)

1. Roden DM., Drug-induced prolongation of the QT interval. N Engl J Med. 2004; 350: 1013-1022. (Pubitemid 38269278)
2. Chiang CE., Congenital and acquired long QT syndrome: current concepts and management. Cardiol Rev. 2004; 12: 222-234.
3. Johri AM, Baranchuk A, Simpson CS, et al. ECG manifestations of multiple electrolyte imbalance: peaked T wave to P wave ("tee-pee sign"). Ann Noninvasive Electrocardiol. 2009; 14: 211-214.
4. Bär KJ, Boettger MK, Koschke M, et al. Increased QT interval variability index in acute alcohol withdrawal. Drug Alcohol Depend. 2007; 89: 259-266. (Pubitemid 46754680)
5. Arizona Center for Education and Research on Therapeutics. QT drug lists by risk groups. Accessed November 14, 2010.
6. Digby G, Machaalany J, Malik P, et al. Multifactorial QT interval prolongation. Cardiol J. 2010; 17: 184-188.
7. Letsas K, Korantzopoulos P, Pappas L, et al. QT interval prolongation associated with venlafaxine administration. Int J Cardiol. 2006; 109: 116-117.
8. Baranchuk A, Simpson CS, Methot M, et al. Corrected QT interval prolongation after an overdose of escitalopram, morphine, oxycodone, zopiclone and benzodiazepines. Can J Cardiol. 2008; 24: e38-e40.
9. Brzozowska A, Werner B., Observation of QTc prolongation in an adolescent girl during fluvoxamine pharmacotherapy. J Child Adolesc Psychopharmacol. 2009; 19: 591-592.
10. Vieweg WV, Wood MA., Tricyclic antidepressants, QT interval prolongation, and torsade de pointes. Psychosomatics. 2004; 45: 371-377. (Pubitemid 39166908)
11. Hustey FM., Acute quetiapine poisoning. J Emerg Med. 1999; 17: 995-997. (Pubitemid 29528071)
12. Sala M, Vicentini A, Brambilla P, et al. QT interval prolongation related to psychoactive drug treatment: a comparison of monotherapy versus polytherapy. Ann Gen Psychiatry. 2005; 4: 1.
13. Simkõ A, Csilek A, Karászi J, et al. Proarrhythmic potential of antimicrobial agents. Infection. 2008; 36: 194-206.
14. Collins KK, Sondheimer JM., Domperidone-induced QT prolongation: add another drug to the list. J Pediatr. 2008; 153: 596-598.
15. Digby GC, Fong C, Methot M, et al. Acquired QT interval prolongation and methadone: the risk of pharmacological interaction. J Clinic Experiment Cardiol. 2011; doi:10.4172/2155-9880.100016.
16. Andrews CM, Krantz MJ, Wedam EF, et al. Methadone-induced mortality in the treatment of chronic pain: role of QT prolongation. Cardiol J. 2009; 16: 211-217.
17. Pérez Riera AR, Uchida AH, Ferreira C, et al. Relationship among amiodarone, new class III antiarrhythmics, miscellaneous agents and acquired long QT syndrome. Cardiol J. 2008; 15: 209-219.
18. Hohnloser SH, Klingenheben T, Singh BN., Amiodarone-associated proarrhythmic effects: a review with special reference to torsade de pointes tachycardia. Ann Intern Med. 1994; 121: 529-535.
19. Papademetriou V., Diuretics, hypokalemia, and cardiac arrhythmia: a 20-year controversy. J Clin Hypertens (Greenwich). 2006; 8: 86-92.
20. Diercks DB, Shumaik GM, Harrigan RA, et al. Electrocardiographic manifestations: electrolyte abnormalities. J Emerg Med. 2004; 27: 153-160. (Pubitemid 38917199)
21. Van den Bergh WM, Algra A, Rinkel GJ., Electrocardiographic abnormalities and serum magnesium in patients with subarachnoid hemorrhage. Stroke. 2004; 35: 644-648. (Pubitemid 38280834)
22. Topol EJ, Lerman BB., Hypomagnesemic torsades de pointes. Am J Cardiol. 1983; 52: 1367-1368. (Pubitemid 14244006)
23. Eryol NK, CÃolak R, ÃzdogÌru Ã, et al. Effects of calcium treatment on QT interval and QT dispersion in hypocalcemia. Am J Cardiol. 2003; 91: 750-752. (Pubitemid 36287477)
24. Clayton JA, Rodgers S, Blakey J, et al. Thiazide diuretic prescription and electrolyte abnormalities in primary care. Br J Clin Pharmacol. 2006; 61: 87-95. (Pubitemid 43381241)
25. Gillis AM, Stoohs R, Guilleminault C., Changes in the QT interval during obstructive sleep apnea. Sleep. 1991; 14: 346-350.
26. Subbiah RN, Gollob MH, Gula LJ, et al. Torsades de pointes during complete atrioventricular block: genetic factors and electrocardiogram correlates. Can J Cardiol. 2010; 26: 208-212.